Rheumatol Int < Rheumatology < Rheumatology International

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Rheumatology

Number of relevant bibliographic references: 51.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
001C42 (2006)	A. P. Risselada [Pays-Bas] ; C. G. M. Kallenberg [Pays-Bas]	Therapy-resistent lupus skin disease successfully treated with rituximab
001C45 (2006)	F. Pessler ; H. Emery [États-Unis] ; L. Dai [République populaire de Chine] ; Y.-M. Wu [République populaire de Chine] ; B. Monash ; R. Q. Cron ; M. Pradhan	The spectrum of renal tubular acidosis in paediatric Sjögren syndrome
001C53 (2006)	F. Falcini [Italie] ; S. Trapani [Italie] ; L. Ricci [Italie] ; M. Resti [Italie] ; G. Simonini [Italie] ; M. De Martino [Italie]	Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment
001D14 (2006)	M. Hammoudeh [Qatar]	Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis
001D17 (2006)	M. N. Lazarus [Royaume-Uni] ; D. Robinson [Royaume-Uni] ; V. Mak [Royaume-Uni] ; H. M Ller [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni]	Incidence of cancer in a cohort of patients with primary Sjögren's syndrome
001D29 (2006)		First Latin American position paper on the pharmacological treatment of rheumatoid arthritis
001E20 (2005)	I. N. Bruce [Royaume-Uni]	‘Not only…but also’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus
001E39 (2005)		SLE and antiphospholipid syndrome [336–364]
001E97 (2005)	T. Kennedy ; C. Mccabe ; G. Struthers ; H. Sinclair ; K. Chakravaty ; D. Bax ; M. Shipley ; R. Abernethy ; T. Palferman [Royaume-Uni] ; R. Hull [Royaume-Uni]	BSR guidelines on standards of care for persons with rheumatoid arthritis
001E98 (2005)	M. J. Leandro [Royaume-Uni] ; G. Cambridge [Royaume-Uni] ; J. C. Edwards [Royaume-Uni] ; M. R. Ehrenstein [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni]	B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients
001F01 (2005)	S. Bernatsky ; M. Hudson ; S. Suissa [Canada]	Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis
001F03 (2005)	A. Rahman [Royaume-Uni] ; S. J. Bowman [Royaume-Uni] ; I. P. Giles [Royaume-Uni] ; Y. Ioannou [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni]	Annus mirabilis—a guide to the 6th European Lupus Meeting, 3–5 March 2005
001F32 (2004)	S. Sollima [Italie] ; M. Corbellino [Italie] ; R. Piolini [Italie] ; S. Calattini [Italie] ; S. Imparato [Italie] ; S. Antinori [Italie]	Visceral leishmaniasis in a patient with Wegener's granulomatosis
001F38 (2004)	C. E. Lampropoulos [Royaume-Uni] ; S. Sangle [Royaume-Uni] ; P. Harrison [Royaume-Uni] ; G. R. V. Hughes [Royaume-Uni] ; D. P. D'Cruz [Royaume-Uni]	Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative
001F40 (2004)	R. Ten Cate ; P. H. Nibbering [Pays-Bas] ; R. G. M. Bredius	Therapy-refractory systemic juvenile idiopathic arthritis successfully treated with statins
001F56 (2004)		SLE and antiphospholipid syndrome [240–264]
001F60 (2004)	A. R. Clewes [Royaume-Uni] ; J. K. Dawson [Royaume-Uni]	Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis
001F91 (2004)	A. Samanta ; L. Goh [Royaume-Uni] ; A. Bawendi	Guidelines for the monitoring of hydroxychloroquine: reply
001F99 (2004)	A. N. Bennett [Royaume-Uni] ; S. R. Sangle [Royaume-Uni] ; G. R. V. Hughes [Royaume-Uni] ; D. P. D Ruz [Royaume-Uni]	Dermatomyositis developing in a Duchenne muscular dystrophy carrier
002009 (2004)	J. Ravindran ; N. Shenker ; A. K. Bhalla ; H. Lachmann [Royaume-Uni] ; P. Hawkins [Royaume-Uni]	Case report: response in proteinuria due to AA amyloidosis but not Felty’s syndrome in a patient with rheumatoid arthritis treated with TNF-α blockade
002021 (2004)	S. Bernatsky ; C. A. Pinaeu ; M. Gans ; A. Clarke [Canada]	Adherence to guidelines for the monitoring of antimalarial-related retinal toxicity

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "Rheumatology" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "Rheumatology" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    Rheumatology
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021